HealthPhoto: Deccan HeraldKerala CPI(M) Defends Stance on Generic SMA Medicine Amid Controversy
In Kerala, a controversy arose over the supply of medicines labeled 'clinical trial' to Spinal Muscular Atrophy (SMA) patients, prompting three former women health ministers to criticize the move. CPI(M) leader Pinarayi Vijayan clarified the party supports generic medicines but opposes unapproved 'clinical trial' supplies. The Congress government confirmed the generic drug by Natco Pharma is approved, with some 'clinical trial' labeled packets distributed due to shortages. The dispute involves Natco's generic version of Roche's costly Evrysdi medicine.
Deccan Herald··Thiruvananthapuram




